Search results for TREM1 antibody

TREM1 antibody [L5-B8.2A12.3A12], Genetex, GTX38897

TREM1 antibody [L5-B8.2A12.3A12], Genetex, GTX38899

Anti-TREM1 antibody [6B1], Abcam, AB90808

ab90808 neutralizes the interaction between TREM1 and its ligand.

Anti-TREM1 antibody [RM1315], Abcam, AB324931

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are recombinant multiclonals? Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including: - The sensitivity of polyclonal antibodies by recognising multiple epitopes - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production View our range of recombinant multiclonal antibodies .

Anti-CD354/TREM1 Antibody (R3W74), AntibodySystem, RHJ62503

Anti-CD354/TREM1 Antibody (R3W75), AntibodySystem, RHJ62502

Anti-TREM1 antibody [EPR22060-229], Abcam, AB225861

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-TREM1 antibody [EPR26206-72], Abcam, AB300461

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-TREM1 antibody [EPR26207-34], Abcam, AB313700

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-TREM1 antibody [L5-B8], Abcam, AB106153